Literature DB >> 2465712

Immunohistochemical evaluation of intermediate filament expression in canine and feline neoplasms.

A S Moore1, B R Madewell, J K Lund.   

Abstract

Specimens of neoplastic tissues from 19 dogs and 4 cats were examined immunohistochemically for intermediate filament expression, using commercially available antibodies. Staining was observed in a wide range of tumor tissues and in normal internal controls by use of antibodies to vimentin, desmin, glial fibrillary acidic protein, and low and high molecular weight cytokeratins. Intermediate filament expression was found to be consistent with light and/or electron microscopic findings, and hence believed to be an accurate indicator of tumor histogenesis in cats and dogs. Three fixatives were evaluated for their relative abilities to preserve antigenicity. Absolute alcohol was superior to B5 fixative and both were superior to formalin. Some tissues that clearly displayed intermediate filament antigens with alcohol and B5 fixative failed to stain when fixed in formalin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465712

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Enzyme immunohistochemical staining of formalin-fixed tissues for diagnosis in veterinary pathology.

Authors:  D M Haines; E G Clark
Journal:  Can Vet J       Date:  1991-05       Impact factor: 1.008

2.  Immunohistochemical detection of intermediate filament proteins in formalin fixed normal and neoplastic canine tissues.

Authors:  M M Desnoyers; D M Haines; G P Searcy
Journal:  Can J Vet Res       Date:  1990-06       Impact factor: 1.310

3.  Expression of secreted frizzled-related protein 2 in a primary canine mammary tumor cell line: a candidate tumor marker for mammary tumor cells.

Authors:  Jia-Lin Lee; Ching-Jin Chang; Ling-Ling Chueh; Chung-Tien Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.